GBS Global Biopharma, Inc.
Records under this name other than the patents GBS Global Biopharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Back to GBS Global Biopharma, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,980,592 | Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases now held by GB Sciences, Inc. In force · High confidence | In force | High confidence | |
| US 10,653,640 | Cannabinoid-Containing Complex Mixtures for the Treatment of Neurodegenerative Diseases now held by GB Sciences, Inc. In force · High confidence | In force | High confidence | |
| 16/686,069 | Therapeutic Nanoparticles Encapsulating Terpenoids And/Or Cannabinoids Abandoned Abandoned Jun 24, 2026 | Abandoned | Abandoned Jun 24, 2026 | |
| 16/914,205 | Treatment of Pain Using Allosteric Modulator of TRPV1 Abandoned Abandoned May 13, 2024 | Abandoned | Abandoned May 13, 2024 | |
| 17/065,400 | Cannabinoid-Containing Complex Mixtures for the Treatment of Mast Cell-Associated or Basophil-Mediated Inflammatory Disorders Abandoned Abandoned Jul 25, 2024 | Abandoned | Abandoned Jul 25, 2024 | |
| 17/406,035 | Cannabinoid-Containing Complex Mixtures for the Treatment of Cytokine Release Syndrome While Preserving Key Anti-Viral Immune Reactions Abandoned Abandoned Sep 18, 2026 | Abandoned | Abandoned Sep 18, 2026 | |
| 17/501,498 | Method and Systems for Phytomedicine Analytics for Research Optimization at Scale Abandoned Abandoned Sep 3, 2026 | Abandoned | Abandoned Sep 3, 2026 | |
| 17/576,485 | TRPV1 Activation-Modulating Complex Mixtures of Cannabinoids And/Or Terpenes Abandoned Abandoned Nov 27, 2024 | Abandoned | Abandoned Nov 27, 2024 | |
| 17/955,425 | Cannabinoid-Containing Formulations for Parkinsonian Movement Disorders now held by GB Sciences, Inc. Abandoned Abandoned Jun 20, 2024 | Abandoned | Abandoned Jun 20, 2024 | |
| 18/601,427 | Cannabinoid-Containing Complex Mixtures for the Treatment of Cytokine Release Syndrome While Preserving Key Anti-Viral Immune Reactions Pending Term is not computable until grant, so no date is shown and no estimate is implied. | Pending | Term is not computable until grant, so no date is shown and no estimate is implied. |